相关实验视频

Updated: May 5, 2026

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

全基因组的CRISPR屏幕识别了KEAP1乱作为ARID1A缺陷细胞的脆弱性

Louis-Alexandre Fournier^1,2, Forouh Kalantari^3,4, James P Wells¹

¹Terry Fox Laboratory, BC Cancer, Vancouver, BC V5L1Z3, Canada.

|September 14, 2024

概括

研究人员发现,抑制KEAP1可选择性地阻止ARID1A缺乏癌细胞的生长,为这些癌症提供了潜在的新治疗策略. 这一发现突显了一种涉及ARID1A损失的合成致命相互作用.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

ARID1A是BAF染色体重塑复合物的关键组成部分,在各种癌症中经常发生突变,特别是清细胞卵巢癌 (CCOC).
失去ARID1A功能会对癌症的发展和进展产生重大影响.
针对ARID1A缺乏癌症的向治疗仍然有限,需要识别新的脆弱性.

研究的目的:

通过全基因组查方法识别ARID1A缺乏癌症的遗传依赖.
探索潜在的合成致命相互作用,这些相互作用可以在ARID1A缺乏的CCOC中进行治疗.
调查ARID1A和KEAP1.1之间观察到的合成致命性背后的机制.

主要方法:

用全基因组的CRISPR查来确定与ARID1A缺陷的遗传相互作用.
KEAP1是通过ARID1A缺陷细胞系的遗传枯竭和化学扰动来准的.
分析了ARID1A缺乏和对照细胞的生长抑制和基因组不稳定性表型.
在ARID1A缺乏细胞中评估了KEAP1-NRF2信号通路的失调.

主要成果:

KEAP1被确定为ARID1A缺乏透明细胞卵巢癌的遗传依赖.
减少或抑制KEAP1可以选择性地抑制ARID1A缺乏细胞的生长,包括初级子宫内膜上皮细胞.
虽然KEAP1-NRF2信号发生了变化,但它并不是合成致命性的主要驱动因素.
发现KEAP1的扰动会加剧与ARID1A缺乏相关的基因组不稳定性.

结论:

在ARID1A缺乏和KEAP1扰动之间发现了一种新的合成致命相互作用.
向KEAP1为ARID1A缺乏癌症提供了一个潜在的治疗策略.
合成致命性似乎与基因组的不稳定性增加有关,而不是异常的NRF2信号传递.

关键词:

在 ARID1A 中.通过CRISPR查进行查.这就是KEAP1的意义.合成杀伤性合成杀伤性

更多相关视频

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

相关概念视频

Adaptations that Reduce Water Loss

Adaptations that Reduce Water Loss

Though evaporation from plant leaves drives transpiration, it also results in loss of water. Because water is critical for photosynthetic reactions and other cellular processes, evolutionary pressures on plants in different environments have driven the acquisition of adaptations that reduce water loss.

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...